CELZ
NASDAQ · Biotechnology
Creative Medical Technology
$0.62
-0.01 (-2.07%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+5,315.2% upside
Low Target
$22.85
Average Target
$33.39
High Target
$43.53
Current Price
$0.62
Current
$0.62
$0.62
Target
$33.39
$33.39
$22.85
$33.39 avg
$43.53
Scenario Analysis
Bear Case
$22.85
3,605.8%
Low target
Base Case
$33.39
+5,315.2%
Avg target
Bull Case
$43.53
+6,959.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.72
-86.9% from high
52-Week Low
$0.59
+4.5% from low
Target vs 52W High
$33.39
+607.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |